Virtus Respiratory Research Ltd is pleased to share that our collaboration with AltesaBiosciences, Inc. has contributed to the successful close of a $75 million oversubscribedSeries B financing.The financing follows positive results from a Phase 2a human...
Thank you for your interest in our clinical trial. This survey should take 2-3 minutes to complete and will be reviewed by the medical team to see whether you would be suitable for our trial. Please note: we will store this confidential medical information securely...
LONDON – VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa...
